Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: To compare the MRI-derived liver surface nodularity (LSN) scores acquired on both 1.5 T and 3 T.
Materials And Methods: Forty chronic liver disease patients who underwent gadoxetic acid-enhanced MRI at both 1.5 and 3 T were included. Axial hepatobiliary phase images with the same voxel size were used to calculate the LSN score in both liver lobes with a quantitative software. Rank correlation, Wilcoxon test, and Bland-Altman limits of agreement were used for statistical analysis.
Results: There was a weak correlation between the right and left liver lobe on 1.5 T (r = 0.331, p = 0.037) and 3 T (r = 0.381, p = 0.015). The correlation between 1.5 T and 3 T on both liver lobes showed a very strong correlation (right, r = 0.927, p < 0.001; left, r = 0.845, p < 0.001). LSN scores differed significantly between both lobes on 1.5 T (median, 1.201 vs. 0.674, right vs. left) and 3 T (1.076 vs. 0.592) (all p < 0.001). LSN scores differed significantly between 1.5 T and 3 T on both lobes (all p < 0.001). The Bland-Altman plot comparing 1.5 T and 3 T on right and left liver lobes showed a systemic bias of 0.08 and 0.07, respectively.
Conclusions: LSN scores differed significantly on 1.5 T vs. 3 T and right vs. left liver lobe. Caution should be made when comparing LSN scores derived from different field strengths or the hepatic lobe. Interplatform, interlobar reproducibility should be resolved to use LSN scores, which is relatively easy to perform without additional hardware or images.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00261-022-03415-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
MRI-Derived Fat Fraction Is Superior to Ultrasonography in Predicting Subclinical Atherosclerosis in Metabolically Healthy Non-alcoholic Fatty Liver Disease.
Cureus
July 2025
Internal Medicine, General Hospital Sector 6 Panchkula, Panchkula, IND.
Background: Subclinical atherosclerosis in metabolic dysfunction-associated steatotic liver disease (MASLD) is well established. However, its presence in patients with metabolically healthy non-alcoholic fatty liver disease (MH-NAFLD) remains unclear.
Aim: To determine the prevalence of subclinical atherosclerosis in patients with MH-NAFLD and to evaluate whether higher grades of hepatic steatosis are associated with increased carotid intima-media thickness (CIMT).
Multiphase MRI-Derived Delta radiomics integrated with clinical features for survival prediction in hepatocellular carcinoma after thermal ablation.
Eur J Radiol
August 2025
Department of Radiology, Huaihe Hospital, Henan University, No. 8 Baobei Road, Gulou District, Kaifeng City 475000 Henan province, China.
Rationale And Objectives: To evaluate the predictive value of a delta radiomic score (DRS)derived from multiphase contrast-enhanced Magnetic Resonance Imaging (MRI), in combination with clinical characteristics, forecasting overall survival (OS) and recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC) after thermal ablation.
Materials And Methods: This retrospective study enrolled 415 patients with HCC from two centers who underwent multiphase contrast-enhanced magnetic resonance imaging and percutaneous thermal ablation. Patients in Institution 1 (n = 315) were randomly assigned to the training cohorts (n = 220) and internal tests (n = 95), while 100 patients in Institution 2 formed the external validation cohort.
Multiparametric MRI Evaluation of Liver Fat and Iron after Glucagon-like Peptide-1 Receptor and Glucagon Receptor Dual-Agonist Treatment in a High-Fat Diet-induced Mouse Model.
Radiology
August 2025
Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Rd, Shanghai 200025, China.
Background Glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR) dual agonist, along with GLP-1R monoagonist, show promise in treating metabolic dysfunction-associated steatotic liver disease (MASLD). Liver fat and iron content are important surrogate markers for disease assessment. However, it remains unclear whether dual agonists provide superior therapeutic benefit over monoagonists for hepatic fat and iron regulation.
View Article and Find Full Text PDFMRI-derived quantification of hepatic vessel-to-volume ratios in chronic liver disease using a deep learning approach.
Eur Radiol Exp
August 2025
Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Background: We aimed to quantify hepatic vessel volumes across chronic liver disease stages and healthy controls using deep learning-based magnetic resonance imaging (MRI) analysis, and assess correlations with biomarkers for liver (dys)function and fibrosis/portal hypertension.
Methods: We assessed retrospectively healthy controls, non-advanced and advanced chronic liver disease (ACLD) patients using a 3D U-Net model for hepatic vessel segmentation on portal venous phase gadoxetic acid-enhanced 3-T MRI. Total (TVVR), hepatic (HVVR), and intrahepatic portal vein-to-volume ratios (PVVR) were compared between groups and correlated with: albumin-bilirubin (ALBI) and "model for end-stage liver disease-sodium" (MELD-Na) score) and fibrosis/portal hypertension (Fibrosis-4 (FIB-4) Score, liver stiffness measurement (LSM), hepatic venous pressure gradient (HVPG), platelet count (PLT), and spleen volume.
Evaluation of photon-counting CT-derived attenuation parameters for noninvasive liver fat assessment.
Eur J Radiol
October 2025
Department of Radiology, Shaoxing People's Hospital, No.568 Zhongxing North Road, 312000 Shaoxing, China; Key Laboratory of Functional Molecular Imaging of Tumor and Interventional Diagnosis and Treatment of Shaoxing City, No.568 Zhongxing North Road, 312000 Shaoxing, China. Electronic address: yang
Objective: To evaluate the diagnostic performance of multiple photon-counting CT (PCCT)-derived parameters for hepatic fat quantification, using MRI-derived proton density fat fraction (PDFF) as the reference standard.
Methods: This prospective study included 59 adult participants who underwent both MRI and PCCT within 2 h. Standardized CT values, Liver-virtual non-contrast (VNC) fat fraction, and liver-to-spleen/fat-derived indices (L-S, L/S, L-F, L + F, L/F) were obtained from non-contrast PCCT.